Mahajna Ahmad, Ott Sascha, Haneya Assad, Leick Jürgen, Pilarczyk Kevin, Shehada Sharaf-Eldin, Bolotin Gil, Lorusso Roberto
Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, P. Debyelaan 25, Maastricht 6202 AZ, The Netherlands.
Cardiac Surgery Department, Rambam Medical Center Campus, PO Box 9602, Haifa 3109601, Israel.
Eur Heart J Suppl. 2025 Feb 4;27(Suppl 4):iv12-iv22. doi: 10.1093/eurheartjsupp/suaf005. eCollection 2025 Apr.
Post-cardiotomy cardiogenic shock (PCCS) is a critical condition characterized by persistent low cardiac output syndrome (LCOS) that manifests either as an inability to wean from cardiopulmonary bypass (CPB) or as severe cardiac dysfunction in the immediate post-operative period despite optimal medical therapy. With an incidence of 2-20%, PCCS is associated with high morbidity, mortality, and healthcare resource utilization. This review explores the pathophysiology of PCCS while emphasizing mechanisms such as direct myocardial damage, ischaemia-reperfusion injury, and systemic effects of extracorporeal circulation. It also discusses key diagnostic tools for PCCS including echocardiography, pulmonary artery catheters, vasoactive inotropic scores (VIS), and lactate clearance, which facilitate early recognition and management. Treatment pathways centred on temporary mechanical circulatory support (tMCS), tailored to clinical scenarios such as the inability to wean from CPB or refractory LCOS. The pivotal role of the multi-disciplinary Heart Team in decision-making, collaboration, and patient-centred care is highlighted. Finally, weaning protocols and considerations for long-term outcomes are discussed, underscoring the need for timely interventions and a personalized approach. Advances in PCCS management continue to evolve, aiming to improve survival and long-term outcomes for this high-risk population.
心脏术后心源性休克(PCCS)是一种危急状况,其特征为持续性低心排血量综合征(LCOS),表现为无法脱离体外循环(CPB),或在术后即刻尽管进行了最佳药物治疗仍出现严重心脏功能障碍。PCCS的发病率为2%-20%,与高发病率、死亡率及医疗资源利用相关。本综述探讨了PCCS的病理生理学,同时强调了诸如直接心肌损伤、缺血再灌注损伤及体外循环的全身影响等机制。还讨论了PCCS的关键诊断工具,包括超声心动图、肺动脉导管、血管活性药物评分(VIS)及乳酸清除率,这些有助于早期识别和管理。治疗途径以临时机械循环支持(tMCS)为中心,根据无法脱离CPB或难治性LCOS等临床情况进行调整。强调了多学科心脏团队在决策、协作及以患者为中心的护理中的关键作用。最后,讨论了脱机方案及对长期结局的考虑因素,强调了及时干预和个性化方法的必要性。PCCS管理方面的进展不断演变,旨在改善这一高危人群的生存率和长期结局。